New ultrasound technique could revolutionize how we monitor muscle disease

NCT ID NCT07378553

Recruiting now Knowledge-focused Sponsor: Nantes University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study is testing whether a special ultrafast ultrasound can better measure muscle changes in boys and men with Duchenne or Becker muscular dystrophy. Researchers will compare muscle stiffness, fat content, and blood flow in 60 participants (patients and healthy volunteers) over 12 months. The goal is to find simple, non-invasive markers that could be used in future treatment trials.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could provide a non-invasive way to track muscle disease progression, helping future clinical trials measure treatment effects more accurately.
What could go wrong: This is an observational study, not a treatment trial. The ultrasound markers may not prove sensitive enough to replace current measures, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BECKER MUSCULAR DYSTROPHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Becker muscular dystrophy Duchenne muscular dystrophy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BECKER MUSCULAR DYSTROPHY DUCHENE MUSCULAR DYSTROPHY

Contacts and locations

Locations

CHU de Nantes
RECRUITING

Nantes, 44093, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.